503b semaglutide FDA Proposal on Semaglutide, Tirzepatide, Liraglutide Exclusion from Bulk List | Chris Munoz, Pharm.D. posted on the topic FDA moves against compounding glp1's

Special Issuance Cases When a medical condition or medication falls outside standard certification pathways, the FAA may deny certification or require a Special Issuance authorization before medical certification can be granted or renewed

Make sure the pharmacy you choose is licensed and follows proper guidelines for compounding medications

Similarly, energy drinks and certain soft drinks often pack a significant sugar content and can contribute to weight gain and unstable blood glucose levels

Meanwhile, in the US, 12.4% of the adult population uses this type of medication, according to Gallups National Health and Well-being Index